CELLECTIS
French limited liability company (société anonyme)
with share capital of € 4.997.776,75
Registered Office: 8, rue de la Croix Jarry - 75013 Paris Paris trade and companies register No. 428 859 052 (the "Company")
Information regarding the director nominee
SHAREHOLDERS MEETING OF JUNE 28, 2024
- NAME AND FIRST NAME: SOURDIVE, David
- DATE AND PLACE OF BIRTH: December 26, 1966 (France)
- AGE : 57
- NATIONALITY : French
- PROFESSIONAL PROFILE AND PROFESSIONAL ACTIVITIES DURING THE PAST FIVE YEARS
On-going:
- MEDLIS, director,
- Exeliom SAS, director,
- Cell-EasySAS, director,
- hema.to GmbH, director,
- Aqemia SAS, director
Past :
- Eukarÿs, SAS, director,
- Omics SAS, director,
- Enobraq, director,
- Mablink SAS, director
6. CURRENT POSITION IN THE COMPANY
Executive Vice President, CMC & Manufacturing
Director, deputy chief executive officer,
7. COMPANY SHARES OWNED BY THE DIRECTOR NOMINEE
987 655 Shares
1 137 325 Stock Options
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cellectis SA published this content on 11 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 June 2024 14:07:03 UTC.